Advancing Cervical Cancer Screening Through Emergency Department-based Self-Sampling
Summary
This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.
Detailed description
This is a single-arm pilot trial with a prospectively enrolled sample. The participants who complete the screening survey and are determined to be adherent (n \~ 600) will be notified that they appear to be adherent with current screening guidelines, and their participation ends at this point. These participants will be considered screen failures for study purposes. Women and transgender/non-binary individuals with a cervix, aged 30-65, will be recruited from a high-volume urban ED. Follow-up will occur at 150 days to determine CC screening activity, perceived and concrete barriers to care, and participant experiences with the intervention. Electronic Health Record (EHR) review will be conducted to corroborate participants' reports of screening activities and assess completion of clinic-based testing and clinical endpoints.
Arms & interventions
- Diagnostic TestCervical Cancer Screening
Subjects will perform self sampling for cervical cancer.
Outcome measures
Primary
Uptake of cervical cancer screening from self-sampling in the ED
Number of subjects referred for additional screening who follow through with next steps in the screening process.
Time frame: In about 150 days of enrollment
Eligibility criteria
Study locations (1)
University of Rochester Strong Memorial Hospital
Rochester, New York, 14642